The GMDN Agency is responsible for the Global Medical Device Nomenclature (GMDN) used to identify medical devices.
MHRA and ANVISA representatives have joined the Authorities Strategic Advisory Group (ASAG) committee, which represents medical device regulators that use the GMDN.
The GMDN Agency delivered three virtual strategy workshops this month (March 2023) as part of our Corporate Strategy 2022 – 2026 implementation.
The GMDN has been listening to the views of nomenclature users to help shape the future of medical device identification.
The GMDN Agency are pleased to welcome a new team member to help us communicate our strategy and engage with all of our stakeholders.